I
nterleukin-17A has biological roles at the interface between the adaptive and innate immune systems (1, 2) . IL-17A contributes to the pathogenesis of multiple autoimmune diseases including rheumatoid arthritis (3) (4) (5) (6) , experimental autoimmune encephalitis (7, 8) , and inflammatory bowel disease (9, 10) through the actions of CD4 ϩ Th17 cells. IL-17A also controls host responses against extracellular pathogens by regulating the expression of many inflammatory mediators including IL-6, CCL2, CXCL1, CXCL6, and CXCL8, as well as G-CSF, GM-CSF, and matrix metalloproteinases (1, 8, 11) .
IL-17A is secreted primarily by three subsets of activated memory T cells, which we have collectively named neutrophil-regulatory Tn cells; CD4 ϩ CD8 Ϫ ␣␤ ϩ (also known as Th17 cells), CD4
Ϫ CD8 Ϫ ␣␤ low T cells, and ␥␦ ϩ T cells (12, 13) . Although most studies have focused on Th17 cells (14, 15) , ␥␦ ϩ T cells are the most abundant IL-17A-producing cells in normal wild-type (WT) 3 mice (12, 13) . The nuclear receptor ROR␥t and the transcription factor Stat3 have been identified as key regulators involved in the polarization of naive CD4 ϩ T cells into Th17 cells following stimulation with IL-6, IL-21, and TGF-␤1 (8, (15) (16) (17) (18) (19) (20) (21) (22) . Replacing the coding region of the ROR␥t gene with that of GFP locus revealed three GFP ϩ cell populations in these mice (19) , analogous to the three populations characterized by Stark et al. (12) . The polarization of Th17 cells can be suppressed by the cytokines IFN-␥ and IL-4, as well as IL-27 and IL-2 (8, (23) (24) (25) .
In mice, IL-17A and IL-17F have a single known homodimeric receptor, IL-17R, which is ubiquitously expressed (26) . In humans, IL-17A and IL-17F can bind to IL-17R alone and to a heterodimeric complex of IL-17R and IL-17RC (27) . IL-17R-deficient mice have much higher mortality rates following infection with Klebsiella pneumoniae or Toxoplasma gondii due to defective neutrophil recruitment to the lung, although the cellular source of IL-17A in these murine models was not determined (28 -30) .
In addition to its role in host defense against infections, our group (12, 31) and others (28 -30, 32, 33) have shown that IL-17A is a potent regulator of granulopoiesis and neutrophil recruitment under normal and inflammatory conditions. Organ-specific overexpression of IL-17A increases circulating neutrophil numbers and recruitment into the organs by induction of CXCL2, IL-1␤, and G-CSF (32) (33) (34) . We have previously shown that blood neutrophil numbers correlate with serum IL-17A and G-CSF levels in normal and adhesion molecule-deficient mice and that G-CSF acts downstream of IL-17A (31) . Neutrophilia is induced by bacterial infection but is also commonly found in adhesion molecule-deficient mice with defective neutrophil trafficking (31, 35) . One such mouse with a severe neutrophil trafficking defect is the Itgb2 Ϫ/Ϫ mouse (36) , which lacks all four ␤ 2 integrins and mimics many aspects of the human leukocyte adhesion deficiency-I (37).
Itgb2
Ϫ/Ϫ mice have 10-to 20-fold elevated neutrophil counts as neutrophils are unable to traffic into many tissues (31, 36) .
In this study, we investigate the role of IL-17R in regulating blood neutrophil numbers using IL-17R-deficient mice with and without neutrophilia. Specifically, we focus on the effects of defective IL-17R signaling on hemopoietic and nonhemopoietic cells, and identify a "short-loop" negative regulatory pathway by which IL-17A regulates the polarization of IL-17A-producing Tn cells through its cognate receptor.
Materials and Methods

Animals
Mice lacking the ␤ 2 integrin subunit (Itgb2 Ϫ/Ϫ ) (36), IL-17R (Il17ra Ϫ/Ϫ ) (29) , and WT C57BL/6 mice (The Jackson Laboratory) were used between 8 and 16 wk of age and kept in specific pathogen-free conditions in a barrier facility. Mice deficient in both CD18 and IL-17R were generated by breeding Itgb2 ϩ/Ϫ with Il17ra Ϫ/Ϫ mice using a standard four generation scheme. All mice were on a C57BL/6 background for at least ten generations, and animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Virginia. For Ab blockade of IL-17A (TC11-18H10.1; BioLegend), 100 g of Ab or rat IgG1 isotype control (eBioscience) per mouse was injected i.v. into WT mice and blood neutrophil counts assessed after 24 h. Blood counts were taken via tail bleed into EDTA-coated capillary tubes, analyzed by automatic analyzer (Hemavet 850; CDC Technologies), and confirmed by Kimura-stained manual counts using a hemocytometer.
Bone marrow (BM) transplantation
BM was isolated from Itgb2
Ϫ/Ϫ and Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice as previously described (38) . In brief, 10 7 BM cells resuspended in 500 l sterile PBS were injected i.v. into lethally irradiated WT or Il17ra Ϫ/Ϫ recipients under sterile conditions. Mice were given autoclaved water supplemented with antibiotics (5 mM sulfamethoxazole, 0.86 mM trimethoprim (SigmaAldrich). All experiments were conducted 8 -9 wk post BM transplantation. Completeness of reconstitution was monitored by amplifying splenocyte DNA of female mice reconstituted with BM from male mice by real-time PCR using primers targeted against the Y6 gene located on the Y chromosome. Reconstitution was ϳ95% (data not shown).
Abs and recombinant proteins
mAbs were from BD Pharmingen: purified or allophycocyanin-conjugated anti-CD3 (145-2C11), allophycocyanin-CY7-or PerCP-conjugated anti-CD4 (RM4-5), anti-CD16/CD32 (2.4G2; The Lymphocyte Culture Center, University of Virginia), purified anti-CD28 (37.51), FITC-or allophycocyanin-conjugated anti-TCR ␤-chain (H57-597), FITC-or biotin-conjugated anti-␥␦ TCR (GL3), purified or PE-conjugated anti-IL-17A (TC11-18H10.1), and PerCP-conjugated streptavidin used for the detection of the biotin-conjugated primary Ab. IL-6 (50 ng/ml; R&D Systems), IL-23 (20 ng/ml; R&D Systems), TGF-␤1 (1 ng/ml; PeproTech), and IL-17A (10 ng/ml; R&D Systems) were used at the concentrations indicated.
Flow cytometry
Animals were anesthetized with an i.p. injection of a mixture containing ketamine hydrochloride (Sanofi Winthrop Pharmaceuticals; 125 mg/kg), xylazine (TranquiVed, Phoenix Scientific; 12.5 mg/kg), and atropine sulfate (Fujisawa USA; 0.025 mg/kg) then killed by cervical dislocation. Single-cell suspensions of the spleen, mesenteric lymph nodes (MLN), and Peyer's patches were prepared by straining tissues through a 70-m screen (BD Falcon). RBC were lysed and white blood cells washed twice with PBS-FBS. Lamina propria (LP) lymphocytes were prepared as previously described (39) . For flow cytometry, cells were cultured in RPMI 1640 containing 10% FBS, 1ϫ nonessential amino acids (Life Technologies), 10 mM HEPES, 2 mM L-glutamine (Life Technologies), 1 mM sodium pyruvate (Life Technologies) and 1% penicillin/streptomycin for 5 h with 10 ng/ml PMA (Sigma-Aldrich), 500 ng/ml calcium ionophore (SigmaAldrich), and GolgiStop (BD Pharmingen).
Following stimulation, cells were re-suspended at 10 7 /ml. Fc␥ III/IIRs were blocked with 0.5 g anti-CD16/CD32 (2.G42) and the cell suspension was incubated with an optimal concentration of mAbs for 20 min at 4°C in staining buffer (5% FBS in PBS) and washed. When biotinylated mAbs were used, streptavidin-PerCP was added for 20 min at 4°C and cells washed twice in staining buffer. Intracellular staining was performed using Fix & Perm cell permeablization reagents (Caltag Laboratories) according to the manufacturer's instructions. Flow cytometry analysis was performed on a Becton Dickinson FACSCalibur dual laser, and data were analyzed using FlowJo software (Tree Star). Gates were set by isotype controls. Alternatively, cells were visualized using Amnis Imagestream100 (Amnis).
Lymphocyte culture
Splenocytes from WT or Il17ra Ϫ/Ϫ mice were isolated under sterile conditions and cultured on plate-adsorbed purified anti-CD3 (10 g/ml) and soluble anti-CD28 (1 g/ml), in the presence or absence of IL-23 (20 ng/ml), IL-6 (50 ng/ml), and TGF-␤1 (1 ng/ml) for 3 days (17). The cell FIGURE 1. Blood neutrophil counts are reduced in IL-17R-deficient mice. Blood neutrophil counts were measured in A IL-17R-deficient mice (n ϭ 14) compared with WT mice (n ϭ 15), in B Il17ra
, and in C WT mice following Ab treatment against IL-17A for 24 h (n ϭ 4 -8;
recipients (n ϭ 5-10) were performed and blood counts assessed after 6 wk. †, p Ͻ 0.05 from all other groups; #, p Ͻ 0.05 compared with Itgb2 suspensions were then transferred to fresh, nontreated plates for 3 days. On day 6, the splenocytes were reactivated for 5 h with 10 ng/ml PMA (SigmaAldrich), 500 ng/ml calcium ionophore (Sigma-Aldrich), and GolgiStop (BD Pharmingen). Alternatively, splenocytes from Itgb2 Ϫ/Ϫ mice were treated with 10 ng/ml IL-17A or IL-17F before being prepared for RNA isolation. IL-17A and G-CSF protein in serum or cell culture supernatants were measured by Quantikine M mouse ELISA kits (R&D Systems) according to the manufacturer's directions.
mRNA quantification
RNA was extracted from isolated splenocytes or tissue following homogenization in Trizol (Invitrogen), according to manufacturer's instructions. Reverse transcription and PCR steps were performed using QuantiTect SYBR Green RT-PCR kit (Qiagen) as previously described (12) . IL-17A primer sequences were as follows:
Sense: ATCCCTCAAAGCTCAGCGTGTC Anti-Sense: GGGTCTTCATTGCGGTGGAGAG FAM-labeled mouse IL-17F and IL-22 Assay on Demand probes and Vic-labeled TaqMan Ribosomal RNA control reagent (Applied Biosystems) were performed using the Quantitech Probe One-Step RT-PCR kit (Qiagen). Then, 1 g of total RNA was used for all tissues. Values were determined using iCycler iQ Real-Time Detection System Software v3.0 (Qiagen). The corresponding values were normalized to 18s RNA and then normalized to individual WT mouse organs as the calibrator control (always equal to 1), thereby expressing the values as relative quantification (RQ) values.
Statistical analysis
Data were expressed as mean Ϯ SEM. Statistical significance between groups was set at p Ͻ 0.05 using unpaired t tests, nonparametric MannWhitney U test, or One-Way ANOVA with Bonferroni's posthoc tests.
Results
IL-17R in nonhemopoietic cells regulates peripheral blood neutrophil counts
Circulating neutrophil numbers were reduced by ϳ37% in Il17ra Ϫ/Ϫ mice compared with WT mice, confirming previous studies (Fig. 1A) (12) . To assess the effects of IL-17R deficiency in cases of severe neutrophilia, Il17ra Ϫ/Ϫ mice were crossed with neutrophilic, adhesion molecule-deficient (Itgb2 Ϫ/Ϫ ) mice. Neutrophil counts were significantly attenuated in Il17ra
mice by ϳ56% compared with Itgb2 Ϫ/Ϫ mice, but absence of IL-17R signaling did not completely rectify the neutrophilia (Fig. 1B) . Under barrier vivarium conditions, Il17ra Ϫ/Ϫ mice did not show any overt phenotype, as previously reported (29) . However, Il17ra
Itgb2
Ϫ/Ϫ mice were consistently smaller in size than Itgb2 Ϫ/Ϫ mice and weighed significantly less (10.5 Ϯ 0.5 g vs 14.7 Ϯ 1.2 g; p Ͻ 0.05). Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice exhibited splenomegaly and extramedullary hematopoiesis causing an expansion in splenic red pulp and subsequent decrease in white pulp. A large infiltration of neutrophils was also found in the lung tissue (data not shown). Furthermore, Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice failed to thrive, and many had to be euthanized between 12 and 14 wk of age. Ab blockade against IL-17A in WT mice caused a significant reduction in neutrophil numbers, by ϳ39%, confirming that IL-17A signaling via IL-17R regulates blood neutrophil numbers in WT mice (Fig. 1C) . 
Ϫ/Ϫ mice and injected i.v. into lethally irradiated WT or Il17ra Ϫ/Ϫ mice. Mice were analyzed 6 -7 wk after BM transfer.
Il17ra
Ϫ/Ϫ mice reconstituted with Itgb2 Ϫ/Ϫ BM had much lower neutrophil counts than WT recipients of Itgb2 Ϫ/Ϫ BM (Fig. 1C) . Their blood neutrophil counts were not significantly different from those of Il17ra Ϫ/Ϫ mice reconstituted with Itgb2 
Ϫ/Ϫ BM have high neutrophil counts but not as high as WT mice reconstituted with Itgb2 Ϫ/Ϫ BM (Fig. 1C) . This suggests that IL-17R on hemopoietic cells also contributes to neutrophil homeostasis, but less than IL-17R on nonhemopoietic cells.
Systemic levels of IL-17A and tissue expression of IL-17A are elevated in IL-17R-deficient mice
Blood sera from Il17ra Ϫ/Ϫ and Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice and their respective control groups were analyzed for IL-17A protein by ELISA. IL-17A was not detectable in WT mice, but was elevated in the sera of Il17ra Ϫ/Ϫ mice (70 Ϯ 22 pg/ml). A significant further elevation in systemic IL-17A levels was seen in Il17ra
Itgb2
Ϫ/Ϫ mice compared with the Itgb2 Ϫ/Ϫ control group ( Fig.  2A) . This suggests that IL-17A secretion may be controlled by an IL-17R-dependent process and this mechanism is defective in Il17ra Ϫ/Ϫ mice. G-CSF levels were not detectable in WT or Il17ra Ϫ/Ϫ mice but were elevated in Itgb2 Ϫ/Ϫ mice. G-CSF levels were significantly reduced in Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice, suggesting that G-CSF is regulated by IL-17A in vivo through IL-17R (Fig. 2B) . IL-17A has also been reported to induce CCL2, CXCL1, and IL-6 release from stromal cells (11) . However, circulating levels of CCL2, CXCL1, and IL-6 were not significantly affected in Il17ra Ϫ/Ϫ mice on either a WT or Itgb2 Ϫ/Ϫ background (data not shown). This excludes a role for these cytokines in the regulation of blood neutrophil numbers and suggests that G-CSF is the major cytokine controlling neutrophil production.
Elevated levels of IL-17A and IL-17A-producing Tn cells in IL-17R-deficient mice
To investigate the sources of the elevated systemic levels of IL-17A seen in Il17ra Ϫ/Ϫ mice, we cultured splenocytes from WT and Il17ra Ϫ/Ϫ mice on plate-absorbed anti-CD3 and soluble anti-CD28 for 3 days in the presence or absence of IL-23, followed by a rest period of 3 days. On day 6, splenocyte cultures were reactivated with a PMA/ionomycin and GolgiStop mixture. In mixed splenocytes, only a small percentage of all cells polarized into IL-17A producers, less than the percentage previously reported for purified naive CD4 ϩ cell cultures (17, 18, 41) . The number of IL-17A-producing Tn cells in Il17ra Ϫ/Ϫ splenocyte cultures was significantly increased compared with WT splenocytes cultures. This difference was further enhanced by treatment with IL-23 (Fig.  3, A and B) . Concomitantly, IL-17A secretion into the cell culture supernatants was also significantly increased in Il17ra Ϫ/Ϫ splenocyte cultures (Fig. 3C) .
In vitro, IL-17A-producing T cells can only be detected following stimulation using PMA/ionomycin. However, detectable serum levels of IL-17A in Il17ra Ϫ/Ϫ , Itgb2 Ϫ/Ϫ , and Il17ra
mice suggests that some T cells actively secrete IL-17A in vivo. To investigate whether basal levels of IL-17A mRNA expression matched the increase in IL-17A protein seen in sera of IL-17R-deficient mice, we monitored IL-17A mRNA expression in various organs (Fig. 4A) . In IL-17R-deficient mice, an increase in IL-17A mRNA expression was found in the lung, spleen, and small intestines, but not the MLN (Fig. 4A) . As reported previously, IL-17A message was elevated in the tissue of Itgb2 Ϫ/Ϫ mice (12) . The levels of IL-17A mRNA were also high in all organs tested (excepting the MLN) of Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice (Fig. 4B) .
IL-17A-producing Tn cell populations are expanded in IL-17R-deficient mice
To investigate the source of elevated IL-17A found in IL-17R-deficient mice, the numbers of IL-17A-producing T cells were assessed in various organs. IL-17A-secreting T cells were significantly expanded in the spleen, MLN, and LP of Il17ra Ϫ/Ϫ mice compared with WT mice, with the majority of IL-17A-producing Tn cells found in the LP (Fig. 5, A-C) . The proportion (%) of Tn cell subsets remained similar between Il17ra Ϫ/Ϫ and WT mice, with ␥␦ ϩ T cells being the major Tn cell population, followed by Th17 cells and then CD4
Ϫ CD8 Ϫ ␣␤ low T cells (Fig. 5B and Table  I ). Representative Th17, CD4 Ϫ
CD8
Ϫ ␣␤ low , and ␥␦ ϩ T cells were analyzed using Amnis technology (Fig. 5E) .
On the neutrophilic (Itgb2 Ϫ/Ϫ ) background, most Tn cells were found in the spleen and LP (Fig. 5D ). The expansion of IL-17A-producing T cells found in the spleen of Itgb2 Ϫ/Ϫ mice was further exacerbated in Il17ra
cells were the major Tn cell population in both Itgb2
Ϫ/Ϫ and Il17ra
mice in all organs assessed. The population of CD4 Ϫ CD8 Ϫ ␣␤ low T cells was also expanded above those of Th17 cells (Table II) .
IL-17R regulates the polarization of IL-17A-producing Tn cells
The expansion of IL-17A-producing Tn cells in IL-17R-deficient mice compared with the control groups led us to hypothesize that IL-17A may negatively regulate the expansion of these cells through IL-17R signaling in an autocrine or paracrine manner. To test this hypothesis, splenocytes were isolated from Itgb2 Ϫ/Ϫ or Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice and cultured as before. IL-17A-producing Tn cells were expanded in Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ splenocyte cultures compared with Itgb2 Ϫ/Ϫ cultures by 48% (Fig. 6A) . IL-17A secretion in the cell culture supernatants was also elevated following cytokine treatment (data not shown).
Treatment of unfractionated Itgb2 Ϫ/Ϫ but not Il17ra
Itgb2
Ϫ/Ϫ splenocytes with rIL-17A or IL-17F for 0 -6 h caused a significant reduction in IL-17A gene expression compared with untreated cells (Fig. 6, B and C) . Furthermore, IL-17A and IL-17F treatments caused a reduction in IL-17F gene expression in (Fig. 6, D and E) . IL-22 mRNA was also down-regulated by 90 -99% in response to IL-17A or F (data not shown). Taken together, these data show that both IL-17A and IL-17F can inhibit their own or each other's production through a short feedback loop that requires IL-17R. Whether this is a T cell autonomous or paracrine process remains to be determined. 
Discussion
Mice lacking IL-17R have reduced neutrophil numbers and G-CSF levels. Most of this effect is due to IL-17R expression on nonhemopoietic cells. IL-17A expression, secretion, and the percentage of IL-17A-producing Tn cells were expanded in IL-17R-deficient mice and IL-17A or IL-17F treatment inhibited IL-17A gene expression. This suggests a short feedback loop by which IL-17A (and probably IL-17F) blunts the expansion of IL-17A-producing T cells in vivo and in vitro. Taken together, our data show a key role for IL-17R signaling in neutrophil homeostasis and in controlling the expansion of IL-17A-producing Tn cells (Fig. 7) . The IL-17R-deficient mouse was first generated by Ye et al. (29) to investigate the role of IL-17R signaling in response to infection by K. pneumoniae. These mice failed to recruit neutrophils into the lung, resulting in 100% mortality. Circulating neutrophil counts in Il17ra Ϫ/Ϫ mice and the cellular source of IL-17A were not reported (29) . As part of its protective role against bacteria, IL-17A has been shown to regulate circulating blood neutrophil counts, with neutrophil numbers positively correlating with IL-17A serum levels in neutrophilic mice (31) . Previous work has shown that irradiated Il17ra Ϫ/Ϫ mice show increased mortality and a dose- We have previously demonstrated that IL-23 regulates both IL-17A and G-CSF secretion in neutrophilic mice (43) . IL-17A regulates G-CSF release from BM-derived stromal cell lines and increases surface expression of stem cell factor, the ligand for c-Kit, in vitro (34) . In this study, we demonstrate that G-CSF secretion was significantly reduced in IL-17R-deficient mice, which became apparent on a neutrophilic background. Mice lacking G-CSF have chronic neutropenia (44) , suggesting that the reduction in neutrophil numbers in Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice probably reflects the lack of G-CSF secretion by BM stromal cells in these mice. Even though large amounts of IL-17A are made, IL-17A is ineffective because the receptor is absent on the relevant cells. However, removing IL-17A signaling in Il17ra Ϫ/Ϫ Itgb2 Ϫ/Ϫ mice did not reduce neutrophil counts to normal WT levels, indicating that other, IL-17R-independent mechanisms can regulate neutrophil numbers in these mice. Such mechanisms might include alternative cytokine pathways.
The increased expression and systemic secretion of IL-17A in IL-17R-deficient mice suggests a possible compensatory mechanism in these mice involving IL-17A. Consistent with our data, Ye et al. (29) found elevated IL-17A levels in the bronchoalveolar lavage fluid of Il17ra Ϫ/Ϫ mice in response to K. pneumoniae infection compared with the control group (29) . Furthermore, the expansion of IL-17A-producing Tn cell numbers in IL-17R-deficient mice (between 3-and 20-fold) suggests that IL-17A may be able to negatively regulate the polarization of IL-17A-producing cells through IL-17R. The cytokines IFN-␥, IL-2, IL-4, and IL-27 have previously been described to limit the polarization of Th17 cells in vitro and in vivo (8, (23) (24) (25) . In this study, we demonstrate the expansion of IL-17A-producing Tn cells in vivo using IL-17R-deficient mice. IL-17R also binds two other ligands, IL-17F and IL-17A/F heterodimers. All three ligands can induce downstream signaling events and the release of inflammatory mediators in vitro and in vivo (26, 27, (45) (46) (47) (48) . Therefore, it is plausible that these ligands may also inhibit the expansion of IL-17A-producing T cells via IL-17R. Indeed, treatment of Itgb2 Ϫ/Ϫ but not Il17ra
Itgb2
Ϫ/Ϫ splenocytes with rIL-17A or IL-17F significantly inhibited IL-17A and IL-17F mRNA expression as well as IL-22, but the effects of IL-17A treatment was stronger and more sustained. Taken together, our results suggest that IL-17A is able to moderate its own secretion by inhibiting the expansion of IL-17A-producing Tn cells.
It is clear that the IL-23/IL-17A/G-CSF axis is responsible for most of the neutrophilia seen in mice lacking ␤ 2 integrins (12, 31, 43) . This pathway may, therefore, also be of key importance in the neutrophilia seen in human leukocyte adhesion deficiency syndromes (37) . The ability of IL-17A to negatively regulate the expansion of IL-17A-producing Tn cells leads us to question the usefulness of anti-IL-17R therapies for autoimmune diseases because they may lead to unwanted expansion of IL-17A-producing T cells. Additionally, if such therapies reduce the circulating neutrophil counts, they can significantly compromise host defense in the patients receiving therapies. It is likely that alternative ways of curbing the proinflammatory effects of IL-17A can be found that circumvent these problems. (12, 13) . The present findings add a "short" feedback loop (bold lines), which negatively regulates IL-17A and IL-17F expression via IL-17R.
